Concepedia

A. Knapp

AK

5

Publications

320

Citations

5

H-Index

2005

Active since

Affiliations

Acadia Pharmaceuticals (United States)(Current)

A. Knapp is an author at Acadia Pharmaceuticals (United States) specializing in small molecules, signal transduction, and drug discovery.

Top concepts

Publications per year

2005–2009

5

Publications

5

Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-Desmethylclozapine as a D2/D3 Partial Agonist

Ethan S. Burstein, Jin Ma, Steven Wong et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 181 citations · Full text

Identification and Characterization of Novel Small-Molecule Protease-Activated Receptor 2 Agonists

Luis R. Gardell, Jian-Nong Ma, Jimmi Gerner Seitzberg et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 51 citations

Discovery of Potent and Selective Small-Molecule PAR-2 Agonists

Jimmi Gerner Seitzberg, A. Knapp, Birgitte W. Lund et al. · Journal of Medicinal Chemistry · 2008 · 36 citations · Full text

, , +15

Design, Synthesis, and Structure−Activity Analysis of Isoform-Selective Retinoic Acid Receptor β Ligands

Birgitte W. Lund, A. Knapp, Fabrice Piu et al. · Journal of Medicinal Chemistry · 2009 · 31 citations · Full text

Pharmacology and Signaling Properties of Epidermal Growth Factor Receptor Isoforms Studied by Bioluminescence Resonance Energy Transfer

Hans H. Schiffer, Esther C. Reding, Stephen R. Fuhs et al. · Molecular Pharmacology · 2006 · 21 citations

Rows per page

1–5 of 5